Definitive Radiation for High-Risk Spine Metastases

Part of paid clinical trials in Stony Brook, New York.

Sponsor
Stony Brook University
Study ID
NCT06165419
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Metastasis
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Lung Cancer
  • Metastatic Tumor
  • Metastatic Tumor of Bone
  • Metastatic Tumor to the Spine
  • Spine Metastases

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • SBRT to the spine — RADIATION
    Stereotactic body radiation therapy (SBRT) administered to spine metastases

Study Details

This study is looking at whether patients with cancer that has aggressively spread to the spine can be treated with stereotactic body radiation therapy only and avoid a large spine surgery

Key Dates

Start date
Dec 14, 2023
Status verified
Apr 2025
Primary completion
May 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
26 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: SBRT to the spine

Primary Outcome Measure

Cumulative incidence of spinal surgery/stabilization within 6 months following SBRT [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stony Brook University HospitalStony BrookNew York11794
Caterina Vacchi-Suzzi, PhD
[email protected]
631-216-2993

Find similar trials in Stony Brook, NY

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Stony Brook University Hospital· Stony Brook, NY

Related Studies